Free Trial

Aura Energy (AURA) Competitors

Aura Energy logo
GBX 7.35 -0.15 (-2.00%)
As of 09:50 AM Eastern

AURA vs. SLN, AMYT, OGN, BMY, GPH, IGC, ARTL, PHAR, KOD, and ORPH

Should you be buying Aura Energy stock or one of its competitors? The main competitors of Aura Energy include Silence Therapeutics (SLN), Amryt Pharma (AMYT), Origin Enterprises (OGN), Bloomsbury Publishing (BMY), Global Ports (GPH), India Capital Growth (IGC), Alpha Real Trust (ARTL), Pharos Energy (PHAR), Kodal Minerals (KOD), and Open Orphan (ORPH). These companies are all part of the "pharmaceutical products" industry.

Aura Energy vs. Its Competitors

Silence Therapeutics (LON:SLN) and Aura Energy (LON:AURA) are both small-cap pharmaceutical products companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, dividends, risk, profitability and media sentiment.

In the previous week, Aura Energy had 3 more articles in the media than Silence Therapeutics. MarketBeat recorded 4 mentions for Aura Energy and 1 mentions for Silence Therapeutics. Aura Energy's average media sentiment score of 0.22 beat Silence Therapeutics' score of 0.00 indicating that Aura Energy is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Silence Therapeutics
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Aura Energy
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral

Silence Therapeutics' return on equity of 0.00% beat Aura Energy's return on equity.

Company Net Margins Return on Equity Return on Assets
Silence TherapeuticsN/A N/A N/A
Aura Energy N/A -0.01%-8.03%

Silence Therapeutics has higher revenue and earnings than Aura Energy. Aura Energy is trading at a lower price-to-earnings ratio than Silence Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Silence Therapeutics£11.35M0.00N/A-£48.60N/A
Aura EnergyN/AN/A-£16.15K-£0.00-16,111.35

59.0% of Aura Energy shares are owned by institutional investors. 20.3% of Aura Energy shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Aura Energy beats Silence Therapeutics on 5 of the 9 factors compared between the two stocks.

Get Aura Energy News Delivered to You Automatically

Sign up to receive the latest news and ratings for AURA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AURA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AURA vs. The Competition

MetricAura EnergyUranium IndustryEnergy SectorLON Exchange
Market Cap£132.10M£3.26B£7.72B£3.10B
Dividend YieldN/A3.08%10.96%5.04%
P/E Ratio-16,111.3544.8374.81171.84
Price / SalesN/A25.1625,268.90297,996.27
Price / Cash7.0017.1035.9027.94
Price / Book0.9839.624.115.28
Net Income-£16.15K£33.15M£4.25B£5.89B
7 Day Performance-1.34%0.82%0.03%0.07%
1 Month Performance2.30%-0.05%0.62%0.80%
1 Year Performance6.83%23.80%8.08%62.31%

Aura Energy Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AURA
Aura Energy
N/AGBX 7.35
-2.0%
N/A+15.5%£132.10MN/A-16,111.3550Gap Up
SLN
Silence Therapeutics
N/AN/AN/AN/A£480.35M£11.35M-11.01100News Coverage
High Trading Volume
AMYT
Amryt Pharma
N/AN/AN/AN/A£457.11M£210.24M-4.33290Gap Down
OGN
Origin Enterprises
N/AGBX 3.78
+1.8%
N/A+20.6%£398.59M£183.08B10.9210,000Dividend Increase
BMY
Bloomsbury Publishing
3.6026 of 5 stars
GBX 493.50
+1.6%
GBX 825
+67.2%
-33.5%£398.22M£382.40M10.5634,300Positive News
Insider Trade
GPH
Global Ports
N/AN/AN/AN/A£231.21M£193.58M30,000.0020
IGC
India Capital Growth
N/AGBX 176
-0.1%
N/A-5.0%£151.96M£46.21M3.5561
ARTL
Alpha Real Trust
N/AN/AN/AN/A£113.12M£8.46M96.445Gap Up
High Trading Volume
PHAR
Pharos Energy
N/AGBX 20.90
-0.5%
N/A-18.0%£104.26M£196.07M-2.22280Positive News
Gap Up
KOD
Kodal Minerals
1.8041 of 5 stars
GBX 0.34
-3.4%
GBX 1.23
+260.3%
-26.5%£68.57MN/A2,613.3790Gap Down
ORPH
Open Orphan
N/AN/AN/AN/A£67.09M£34.71M-25.30179

Related Companies and Tools


This page (LON:AURA) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners